amrinone has been researched along with Weight Gain in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The development of anterior ischemic optic neuropathy was associated with prolonged cardiopulmonary bypass time, low hematocrit levels, excessive perioperative body weight gain, and the use of epinephrine and amrinone." | 3.69 | Anterior ischemic optic neuropathy after open heart operations. ( Kimmel, WA; Lindsey, PS; Shahian, DM; Shapira, OM, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shapira, OM | 1 |
| Kimmel, WA | 1 |
| Lindsey, PS | 1 |
| Shahian, DM | 1 |
1 other study available for amrinone and Weight Gain
| Article | Year |
|---|---|
Anterior ischemic optic neuropathy after open heart operations.
Topics: Aged; Amrinone; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Epinephrine; Female; Hematocrit | 1996 |